Lataa...
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is considered to be a hepatic manifestation of metabolic syndrome, and its incidence is rapidly increasing worldwide. It is currently the most common chronic liver disease. NASH can progress to liver cirrhosis and hepatocel...
Tallennettuna:
| Julkaisussa: | World J Gastroenterol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4385525/ https://ncbi.nlm.nih.gov/pubmed/25852263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i13.3777 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|